Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Disease Progression; Piperazines; Pyridines; Receptors, Estrogen; Receptors, Progesterone; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Protein Kinase Inhibitors; Adult; Aged
- PubMed ID
- 38513188
- Added to directory
- Source checked